Dose-dependent neurochemical and functional protection afforded by encapsulated CNTF-producing cells

Cell Transplantation

Volumn 13, Issue 7-8, 2004, Pages 839-844

  Emerich, Dwaine F ^a  

^a LCT BioPharma Inc   (United States)

Author keywords

CNTF; Encapsulation; Gene therapy; Huntington's disease; Neurodegeneration; Striatum; Xenotransplantion

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; QUINOLINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ENCAPSULATION; CONTROLLED STUDY; HUNTINGTON CHOREA; LATERAL BRAIN VENTRICLE; MALE; NEUROCHEMISTRY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; XENOTRANSPLANTATION;

ANIMALIA; RODENTIA;

EID: 14044251519     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000004783983404     Document Type: Article

References (25)

1. Bachoud-Levi, A. C.; Deglon, N.; Nguyen, J.-P.; Bloch, J.; Bourdet, C.; Winkel, L.; Remy, P.; Goddard, M.; Lefaucher, J. P.; Brugieres, P.; Baudic, S.; Cesaro, P.; Peschanski, M.; Aebischer, P. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. Hum. Gene Ther. 11:1723-1729; 2000.
2. Choi, D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634; 1988.
3. deAlmeida, L. P.; Zala, D.; Aebischer, P.; Deglon, N. Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease. Neurobiol. Dis. 8:433-446; 2001.
4. Emerich, D. F.; Hammang, J. P.; Baetge, E. E.; Winn, S. R. Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum. Exp. Neurol. 130: 141-150; 1994.
5. Emerich, D. F.; Winn, S. R.; Lindner, M. D.; Frydel, B. R.; Kordower, J. H. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease. J. Neurosci. 16:5168-5181; 1996.
6. Emerich, D. F.; Cain, C. K.; Greco, C.; Saydoff, J. A.; Hu, Z. -Y.; Liu, H.; Lindner, M. D. Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease. Cell Transplant. 6:249-266; 1997.
7. Emerich, D. F.; Winn, S. R.; Chen, E.-Y.; Chu, Y.; McDermott, P.; Baetge, E.; Kordower, J. H. Protection of basal ganglia circuitry by encapsulated CNTF-producing cells in a primate model of Huntington's disease. Nature 386:395-399; 1997.
8. Emerich, D. F.; Winn, S. R. Neuroprotective effects of encapsulated CNTF-producing cells in a rodent model of Huntington's disease are dependent on the proximity of the implant to the lesioned striatum. Cell Transplant. 13: 253-259; 2004.
9. Frim, D. M.; Schumacher, J. M.; Short, M. P.; Breakefield, X. O.; Isacson, O. Local response to intracerebral grafts of NGF-secreting fibroblasts: Induction of a peroxidative enzyme. Soc. Neurosci. Abstr. 18:1100; 1992.
10. Frim, D. M.; Uhler, T. A.; Short, M. P.; Exxedine, Z. D.; Klagsbrun, M.; Breakefield, X. O.; Isacson, O. Effects of biologically delivered NGF, BDNF, and bFGF on striatal excitotoxic lesions. Neuroreport 4:367-370; 1993.
11. Frim, D. M.; Simpson, J.; Uhler, T. A.; Short, M. P.; Bossi, S. R.; Breakefield, X. O.; Isacson, O. Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF. J. Neurosci. Res. 35:452-458; 1993.
12. Jackson, G.; Apffel, L.; Werrbach-Perez, K.; Perez-Polo, J. R. Role of nerve growth factor in oxidant-antioxidant balance and neuronal injury. I. Stimulation of hydrogen peroxide resistance. J. Neurosci. Res. 25:360-368; 1990.
13. Kordower, J. H.; Chen, E.-Y.; Mufson, E. J.; Winn, S. R.; Emerich, D. F. Intrastriatal implants of polymer-encapsulated cells genetically modified to secrete human NGF: Trophic effects upon cholinergic and noncholinergic neurons. Neuroscience 72:63-77; 1996.
14. Kordower, J. H.; Isacson, O.; Emerich, D. F. Cellular delivery of trophic factors for the treatment of Huntington's disease: Is neuroprotection possible? Exp. Neurol. 159:4-20; 1999.
15. MacLennan, J. A.; Vinson, E. N.; Marks, L.; McLaurain, D. L.; Pfiefer, M.; Lee, M. Immunohistochemical localization of ciliary neurotrophic factor receptor alpha expression in the rat nervous system. J. Neurosci. 16:621-630; 1996.
16. Mattson, M. P.; Cheng, B.; Smith-Swintosky, V. L. Mechanisms of neurotrophic factor protection against calcium-and free radical-mediated excitotoxic injury: Implications for treating neurodegenerative disorders. Exp. Neurol. 124:89-95; 1993.
17. Mittoux, V.; Joseph, J. M.; Conde, F.; Palfi, S.; Dautry, C.; Poyot, T.; Bloch, J.; Deglon, N.; Ouary, S.; Nimchinsky, E. A.; Brouillet, E.; Hof, P.l R.; Peschanski, M.; Aebischer, P.; Hantraye, P. Restoration of cognitive and motor function with ciliary neurotrophic factor in a primate model of Huntington's disease. Hum. Gene. Ther. 11:1177-1187; 2000.
18. Mittoux, V.; Quary, S.; Monville, C.; Lisovoski, F.; Poyot, T.; Conde, F.; Escartin, C.; Robichon, R.; Brouillet, E.; Peschanski, M.; Hantraye, P. Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration. J. Neurosci. 22:4478-4486; 2002.
19. Penney, J. B.; Young, A. B.; Shoulson, I. Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov. Disord. 5:93-99; 1990.
20. Regulier, E.; Perreira de Almeida, L.; Sommer, B.; Aebischer, P.; Deglon, N. Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease. Hum. Gene Ther. 13: 1981-1990; 2002.
21. Rothman, S. M. The neurotoxicity of excitatory amino acids is produced by passive chloride influx. J. Neurosci. 5:1483-1490; 1985.
22. + pump necessary for NGF-mediated neuronal survival? J. Neurosci. 8:458-462; 1988.
23. Shoulson, I. Huntington's disease: Functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology 31:1333-1335; 1981.
24. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-978; 1993.
25. Winn, S. R.; Lindner, M. D.; Haggett, G.; Francis, J. M.; Emerich, D. F. Polymer-encapsulated genetically-modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: Behavioral and anatomical consequences. Exp. Neurol. 140:126-138; 1996.